Skip to main content
Top
Published in: Molecular Imaging and Biology 2/2014

01-04-2014 | Brief Article

Detection of the Prodrug-Activating Enzyme Carboxypeptidase G2 Activity with Chemical Exchange Saturation Transfer Magnetic Resonance

Authors: Yann Jamin, Thomas R. Eykyn, Evon Poon, Caroline J. Springer, Simon P. Robinson

Published in: Molecular Imaging and Biology | Issue 2/2014

Login to get access

Abstract

Purpose

The purpose of this study is to evaluate if the differential exchange rates with bulk water between amine and amide protons can be exploited using chemical exchange saturation transfer magnetic resonance (CEST-MR) to monitor the release of glutamate induced by carboxypeptidase G2 (CPG2), an enzyme utilized in cancer gene therapy.

Procedures

Z spectra of solutions of the CPG2 substrate, 3,5-difluorobenzoyl-l-glutamate (amide), and glutamate (amine) were acquired at 11.7 T, 37 °C, across different pH (5–8). The ability of CEST-MR to monitor CPG2-mediated release of glutamate was assessed in extracts of CPG2-expressing cancer cells and purified solution of CPG2.

Results

The addition of CPG2 to a solution containing 3,5-difluorobenzoyl-l-glutamate led to a marked and progressively increasing CEST effect (+3 ppm), concomitant with the time-dependent release of glutamate induced by CPG2.

Conclusion

CEST-MR allows the detection of CPG2 activity in vitro and supports the translation of CEST-MRI to assess CPG2-based gene therapy in vivo.
Literature
3.
go back to reference Niculescu-Duvaz D, Niculescu-Duvaz I, Springer CJ (2004) Design of prodrugs for suicide gene therapy. Methods Mol Med 90:161–202PubMed Niculescu-Duvaz D, Niculescu-Duvaz I, Springer CJ (2004) Design of prodrugs for suicide gene therapy. Methods Mol Med 90:161–202PubMed
4.
go back to reference Hedley D, Ogilvie L, Springer C (2007) Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury. Nat Rev Cancer 7:870–879PubMedCrossRef Hedley D, Ogilvie L, Springer C (2007) Carboxypeptidase-G2-based gene-directed enzyme-prodrug therapy: a new weapon in the GDEPT armoury. Nat Rev Cancer 7:870–879PubMedCrossRef
5.
go back to reference Penet M-F, Chen Z, Li C, Winnard P, Bhujwalla Z (2012) Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage. Drug Deliv Transl Res 2:22–30PubMedCentralPubMedCrossRef Penet M-F, Chen Z, Li C, Winnard P, Bhujwalla Z (2012) Prodrug enzymes and their applications in image-guided therapy of cancer: tracking prodrug enzymes to minimize collateral damage. Drug Deliv Transl Res 2:22–30PubMedCentralPubMedCrossRef
6.
go back to reference Jamin Y, Smyth L, Robinson SP et al (2011) Noninvasive detection of carboxypeptidase G2 activity in vivo. NMR Biomed 24:343–350PubMed Jamin Y, Smyth L, Robinson SP et al (2011) Noninvasive detection of carboxypeptidase G2 activity in vivo. NMR Biomed 24:343–350PubMed
7.
go back to reference Marais R, Spooner RA, Stribbling SM et al (1997) A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy. Nat Biotechnol 15:1373–1377PubMedCrossRef Marais R, Spooner RA, Stribbling SM et al (1997) A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy. Nat Biotechnol 15:1373–1377PubMedCrossRef
8.
go back to reference Schepelmann S, Hallenbeck P, Ogilvie LM et al (2005) Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2. Cancer Res 65:5003–5008PubMedCrossRef Schepelmann S, Hallenbeck P, Ogilvie LM et al (2005) Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2. Cancer Res 65:5003–5008PubMedCrossRef
9.
go back to reference Jamin Y, Gabellieri C, Smyth L et al (2009) Hyperpolarized (13)C magnetic resonance detection of carboxypeptidase G2 activity. Magn Reson Med 62:1300–1304PubMedCrossRef Jamin Y, Gabellieri C, Smyth L et al (2009) Hyperpolarized (13)C magnetic resonance detection of carboxypeptidase G2 activity. Magn Reson Med 62:1300–1304PubMedCrossRef
10.
go back to reference Liu G, Liang Y, Bar-Shir A et al (2011) Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. J Am Chem Soc 133:16326–16329PubMedCentralPubMedCrossRef Liu G, Liang Y, Bar-Shir A et al (2011) Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. J Am Chem Soc 133:16326–16329PubMedCentralPubMedCrossRef
11.
go back to reference Schepelmann S, Ogilvie LM, Hedley D et al (2007) Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2. Cancer Res 67:4949–4955PubMedCrossRef Schepelmann S, Ogilvie LM, Hedley D et al (2007) Suicide gene therapy of human colon carcinoma xenografts using an armed oncolytic adenovirus expressing carboxypeptidase G2. Cancer Res 67:4949–4955PubMedCrossRef
12.
go back to reference Hirayama A, Kami K, Sugimoto M et al (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69:4918–4925PubMedCrossRef Hirayama A, Kami K, Sugimoto M et al (2009) Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Res 69:4918–4925PubMedCrossRef
Metadata
Title
Detection of the Prodrug-Activating Enzyme Carboxypeptidase G2 Activity with Chemical Exchange Saturation Transfer Magnetic Resonance
Authors
Yann Jamin
Thomas R. Eykyn
Evon Poon
Caroline J. Springer
Simon P. Robinson
Publication date
01-04-2014
Publisher
Springer US
Published in
Molecular Imaging and Biology / Issue 2/2014
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI
https://doi.org/10.1007/s11307-013-0680-5

Other articles of this Issue 2/2014

Molecular Imaging and Biology 2/2014 Go to the issue